companydata.dkcompanydata.dk

SCANORTO A/S: Financial statements 2020

CVR: 12687648

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

SCANORTO A/S (CVR 12687648) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 6,725,513 and a net result of DKK 732,626 compared with DKK 562,957 the year before. That is an increase of 4.4% compared with the year before. Equity in the 2020 report amounted to DKK 6,529,125. The solvency ratio was 39.2%. The company had 10 employees in the financial year.

Gross Profit
DKK 6,725,513
Profit/Loss
DKK 732,626
Equity
DKK 6,529,125
Total Assets
DKK 16,636,423
Employees
10

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-6.7 mio.733 t.6.5 mio.10
2019-6.4 mio.563 t.5.8 mio.10
2018-8.2 mio.1.1 mio.5.2 mio.10
2017-8.6 mio.264 t.4.1 mio.11
2015-11.7 mio.-3.5 mio.2.6 mio.18

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SCANORTO A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

SCANORTO A/S appoints new auditorNov 24, 2020

As of November 24, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of SCANORTO A/S.

Auditor steps down at SCANORTO A/SNov 24, 2020

As of November 24, 2020, EY Godkendt Revisionspartnerselskab has stepped down as auditor of SCANORTO A/S.

SCANORTO A/S: The 2019 annual report is outJul 6, 2020

SCANORTO A/S has published its annual report for 2019. Gross profit came to DKK 6,444,389, and the net result was DKK 562,957.

About SCANORTO A/S

SCANORTO A/S is a Danish company of the type Aktieselskab based in Kgs. Lyngby, founded in 1989. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LASSE LAGER HOLDING ApS and ASX 14746 ApS. The management consists of Karel Rajchert. The board consists of Karel Budka (chair), Filipa Alexandra Pinto De Almeida and Karel Rajchert. The company is owned by NOBEL BIOCARE DANMARK A/S. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. Equity in the 2025 report amounted to DKK 12,950,705.

Source: annual report 2025, Danish Business Authority